BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 17159598)

  • 1. Toward individualized treatment: prediction of anticancer drug disposition and toxicity with pharmacogenetics.
    Deeken JF; Figg WD; Bates SE; Sparreboom A
    Anticancer Drugs; 2007 Feb; 18(2):111-26. PubMed ID: 17159598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomics of drug-metabolizing enzymes and drug transporters in chemotherapy.
    Bosch TM
    Methods Mol Biol; 2008; 448():63-76. PubMed ID: 18370231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic polymorphisms of drug-metabolising enzymes and drug transporters in the chemotherapeutic treatment of cancer.
    Bosch TM; Meijerman I; Beijnen JH; Schellens JH
    Clin Pharmacokinet; 2006; 45(3):253-85. PubMed ID: 16509759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer treatment and pharmacogenetics of cytochrome P450 enzymes.
    van Schaik RH
    Invest New Drugs; 2005 Dec; 23(6):513-22. PubMed ID: 16267627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotyping and phenotyping cytochrome P450: perspectives for cancer treatment.
    Mathijssen RH; van Schaik RH
    Eur J Cancer; 2006 Jan; 42(2):141-8. PubMed ID: 16325399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetics for individualized cancer chemotherapy.
    Efferth T; Volm M
    Pharmacol Ther; 2005 Aug; 107(2):155-76. PubMed ID: 15890408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotypes Affecting the Pharmacokinetics of Anticancer Drugs.
    Bertholee D; Maring JG; van Kuilenburg AB
    Clin Pharmacokinet; 2017 Apr; 56(4):317-337. PubMed ID: 27641154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer pharmacogenomics: achievements in basic research.
    Nakajima M; Yokoi T
    Int J Clin Oncol; 2005 Feb; 10(1):14-9. PubMed ID: 15729595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetics of tipifarnib (R115777) transport and metabolism in cancer patients.
    Sparreboom A; Marsh S; Mathijssen RH; Verweij J; McLeod HL
    Invest New Drugs; 2004 Aug; 22(3):285-9. PubMed ID: 15122075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer pharmacogenomics: international trends.
    Yamayoshi Y; Iida E; Tanigawara Y
    Int J Clin Oncol; 2005 Feb; 10(1):5-13. PubMed ID: 15729594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYP450 pharmacogenetics for personalizing cancer therapy.
    van Schaik RH
    Drug Resist Updat; 2008 Jun; 11(3):77-98. PubMed ID: 18486526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individualized drug therapy.
    Daly AK
    Curr Opin Drug Discov Devel; 2007 Jan; 10(1):29-36. PubMed ID: 17265738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetics in cancer treatment.
    Nagasubramanian R; Innocenti F; Ratain MJ
    Annu Rev Med; 2003; 54():437-52. PubMed ID: 12525681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetics/genomics of membrane transporters in cancer chemotherapy.
    Huang Y
    Cancer Metastasis Rev; 2007 Mar; 26(1):183-201. PubMed ID: 17323126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacogenetics of anticancer drugs].
    de Chaisemartin L; Loriot MA
    Pathol Biol (Paris); 2005 Mar; 53(2):116-24. PubMed ID: 15708657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetics in cancer chemotherapy: balancing toxicity and response.
    Donnelly JG
    Ther Drug Monit; 2004 Apr; 26(2):231-5. PubMed ID: 15228171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances and challenges in hereditary cancer pharmacogenetics.
    Cascorbi I; Werk AN
    Expert Opin Drug Metab Toxicol; 2017 Jan; 13(1):73-82. PubMed ID: 27603572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetics of analgesics: toward the individualization of prescription.
    Rollason V; Samer C; Piguet V; Dayer P; Desmeules J
    Pharmacogenomics; 2008 Jul; 9(7):905-33. PubMed ID: 18597654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetics in cancer etiology and chemotherapy.
    Boddy AV; Ratain MJ
    Clin Cancer Res; 1997 Jul; 3(7):1025-30. PubMed ID: 9815780
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacogenomic approaches for prevention of drug toxicity in cancer chemotherapy].
    Hasegawa Y
    Gan To Kagaku Ryoho; 2003 Mar; 30(3):325-33. PubMed ID: 12669388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.